|
APRE Aprea Therapeutics Inc 1781983 |
| Balance Sheet |
|
Current Assets
|
26,483,820 |
|
Assets
|
26,893,969 |
|
Current Liabilities
|
3,635,888 |
|
Liabilities
|
4,946,951 |
|
Equity
|
21,947,018 |
|
Shares Out
|
5,432,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-10,045,814 |
|
Investing Cash Flow
|
-15,478 |
| Market Analysis |
Market Cap
|
16,839,435 |
|
Price
|
3.95 |
|
BVPS
|
4.04 |
|
PB
|
0.99 |
|
EPS
|
-3.03 |
|
PS
|
0.08 |
|
FCF
|
-10,061,292 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view APRE documents filed with the SEC.
APRE Filings
Clear
